COVID-19 infection. Covid-19, confirmed cases, positive test result
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: cases who diagnosed as COVID-19 infection by clinical features; laboratory findings (positive C Reactive Protein, Chest X-ray findings, CT scan findings) clinical/lab confirmation of the disease hospitalization due to COVID-19 Stated willingness to participate in the study and sign a written informed consent document
Exclusion criteria
Exclusion criteria: Significant allergic reactions to the herbal drug History of CHF, liver and kidney disorders Patients with diabetes or other endocrine disorders People who are constantly monitored and treated with psychiatric drugs Pregnant/ breast feeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical/lab confirmation of the disease. Timepoint: Weekly after intervention. Method of measurement: Examination- PCR test.;Hospitalization due to Covid-19. Timepoint: Weekly after intervention. Method of measurement: Hospital report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of COVID-19 symptoms at end of treatment. Timepoint: End of Treatment (7 days after staring intervention). Method of measurement: General condition of the patient (clinical symptoms). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences